Stock Evaluator: Medtronic plc (MDT)

2,099 followers

Medtronic plc MDT

$86.68 1.29 1.51%
August 3, 2026 4:00:02 PM EST November 10, 2021 Volume: 6,783,742
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Commentary & Analysis


Financial Summary

Share Statistics MDT Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $109,303.1 $337.2 97%
Shares Out (Mil) 1,288.2 41.9 95%
Institutional Ownership 99.9% 77.8% 96%
Float (Mil) 1,277.5 34.7 93%
Beta 0.58 0.85 33%
Avg Daily Volume (000s) 7,275 278 95%
Price Change
(52-week)
(6.8%) 58.7% 40%
Growth MDT Industry
Median
Percentile
(All Stocks)
Sales (5yr) 3.8% 11.8% 30%
Net Income (5yr) 5.9% (5.8%) 48%
EPS (5yr) 7.0% 11.4% 41
Dividends (5yr) 4.1% 0.0% 93%
Cash Flow (5yr) 12.5% (16.3%) 71%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 24 28 29
Current EPS $1.388 $5.949 $6.412
Month Ago EPS $1.388 $5.948 $6.405
# Rev Up 2 1 0
# Rev Down 0 0 1
Three Months Ago EPS $1.380 $6.059 $6.542
Year/Year Chg 43.1% 59.5% 86.3%
Financials MDT Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $36,364 $152 95%
Net Income (TTM) (Mil) $4,801 ($10) 97%
EPS (TTM) $3.746 ($0.500) 82%
Operating Cash Flow (TTM) (Mil) $7,330 ($2) 97%
Net Cash Flow (TTM) (Mil) ($270) $1 8%
Long-Term Debt (Q1) (Mil) $27,163 $22 97%
Enterprise Value (Q1) (Mil) $132,463 $304 97%
Valuation MDT Industry
Median
Percentile
(All Stocks)
P/B 2.21 2.80 54%
P/E 22.9 31.1 57%
Dividend Yield 3.3% 0.0% 87%
PEG (5yr hist) 3.3 1.9 79%
Ratios MDT Industry
Median
Percentile
(All Stocks)
Gross Margin 65.3% 59.1% 77%
Net Margin 13.2% (7.3%) 70%
ROA 5.2% (13.7%) 73%
ROE 9.8% (15.8%) 57%
Liabilities to Assets 46.2% 44.7% 37%
F-Score 7 4 84%

Medtronic plc did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors